Xiangguo Li

ORCID: 0000-0002-4969-9962
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Eicosanoids and Hypertension Pharmacology
  • Glycosylation and Glycoproteins Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • Pediatric health and respiratory diseases
  • Cancer, Hypoxia, and Metabolism
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Lung Cancer Research Studies
  • Circular RNAs in diseases

Wenzhou Medical University
2020-2022

Background: Numerous studies have recorded the function of long noncoding RNAs (lncRNAs) in cancer development, including lung adenocarcinoma (LUAD). Previous reported crucial role lncRNA PTPRG antisense RNA 1 (PTPRG-AS1) various cancers. However, PTPRG-AS1 LUAD remains unknown. Materials and Methods: Real-time quantitative polymerase chain reaction (RT-qPCR) was applied for detecting expression cell lines. Functional assays vivo experiments explored proliferation, whereas flow cytometry...

10.1089/cbr.2021.0168 article EN Cancer Biotherapy and Radiopharmaceuticals 2021-11-12

Background: Lung cancer (LC) represents a leading cause of cancer-related deaths. The aim this study was to analyze the application value ZIC5 in prognosis evaluation LC. Materials and Methods: mRNA protein levels LC tissues adjacent normal controls were detected by quantitative real-time polymerase chain reaction Western blot analysis, respectively. Chi-square test performed estimate association between expression clinical features. Furthermore, overall survival (OS) curves plotted using...

10.1089/cbr.2020.3775 article EN Cancer Biotherapy and Radiopharmaceuticals 2020-07-07

Abstract Background: Asthma is a common chronic airway inflammation that produces healthcare burden on the economy. To obtain better understanding of clinical status and disease patients with asthma in China. Methods: A retrospective study based computerized medical records Jinan Health Medical Big Data Platform between 2011 2019 (n = 31,082) was carried out. The severity each patient assessed retrospectively categorized as mild, moderate, or severe according to GINA 2018. Results: results...

10.21203/rs.3.rs-1157824/v2 preprint EN cc-by Research Square (Research Square) 2022-02-03
Coming Soon ...